BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹58,540 Cr | ₹55,753 Cr | ₹51,742 Cr | ₹20,101 Cr | ₹18,215 Cr |
What is the latest Total Liabilities ratio of BIOCON ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹58,540 Cr |
| Mar2024 | ₹55,753 Cr |
| Mar2023 | ₹51,742 Cr |
| Mar2022 | ₹20,101 Cr |
| Mar2021 | ₹18,215 Cr |
How is Total Liabilities of BIOCON Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹58,540 Cr | 5.00 | |
| Mar2024 | ₹55,753 Cr | 7.75 | |
| Mar2023 | ₹51,742 Cr | 157.41 | |
| Mar2022 | ₹20,101 Cr | 10.35 | |
| Mar2021 | ₹18,215 Cr | - | |
Compare Total Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹61,237.6 Cr | 1% | -0.3% | -2.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 1% |
-0.3% |
-2.9% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses